| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |